4.7 Article

Crystal Structure of Human Aurora B in Complex with INCENP and VX-680

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 17, Pages 7841-7848

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm3008954

Keywords

-

Funding

  1. Canadian Institutes for Health Research
  2. Canada Foundation for Innovation
  3. Genome Canada
  4. GlaxoSmithKline
  5. Lilly Canada
  6. Novartis Research Foundation
  7. Pfizer
  8. Takeda
  9. Ontario Ministry of Economic Development and Innovation
  10. Wellcome Trust
  11. Italian Foundation for Cancer Research
  12. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

Ask authors/readers for more resources

We present the structure of the human Aurora B kinase domain in complex with the C-terminal Aurora-binding region of human INCENP and the Aurora kinase inhibitor VX-680. The structure unexpectedly reveals a dimeric arrangement of the Aurora B:INCENP complex, which was confirmed to exist in solution by analytical ultracentrifugation. The dimerization involves a domain swap of the activation loop, resulting in a different conformation of the DFG motif as compared to that seen in other kinase complexes with VX-680. The binding of INCENP differs significantly from that seen in the Xenopus laevis Aurora B:INCENP complex currently used as a model for structure-based design for this important oncology target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity

Vaclav Nemec, Prashant Khirsariya, Pavlina Janovska, Paula Martin Moyano, Lukas Maier, Petra Prochazkova, Pavlina Kebkova, Tomas Gybel', Benedict-Tilman Berger, Apirat Chaikuad, Maria Reinecke, Bernhard Kuster, Stefan Knapp, Vitezslav Bryja, Kamil Paruch

Summary: In this study, a new class of potent and highly selective inhibitors of CK1 alpha, delta and epsilon were identified. MU1250, MU1500 and MU1742 were selected as quality chemical probes for those CK1 isoforms due to their optimal in vitro and in vivo profiles and exclusive selectivity. Furthermore, it was found that the central 1H-pyrrolo[2,3-b]pyridine-imidazole pharmacophore can be used as the basis of highly selective inhibitors of other therapeutically relevant protein kinases, such as p38 alpha.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Biology

Profilin 1 deficiency drives mitotic defects and reduces genome stability

Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco

Summary: Profilin 1, encoded by PFN1, is a protein that plays a tumor suppressive role in various adenocarcinomas and pagetic osteosarcomas. However, its exact contribution to tumor development is not fully understood. This study shows that inactivation of Profilin 1 leads to multiple mitotic defects, resulting in chromosomal instability and genome rearrangements in pagetic osteosarcomas. Mechanistically, Profilin 1 is involved in regulating cell division and its deficiency impairs actin filament supply during cytokinesis.

COMMUNICATIONS BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells

Mohamed Hasyeoui, Frederic Lassagne, William Erb, Manal Nael, Khaled M. Elokely, Apirat Chaikuad, Stefan Knapp, Adrian Jorda, Soraya L. Vall, Emie Quissac, Maite Verreault, Thomas Robert, Stephane Bach, Ali Samarat, Florence Mongin

Summary: The effects of FL-291 on the viability of neuroblastoma cells were investigated and found to have no significant impact on cell survival. Structural analysis revealed similar binding modes for FL-291 and CD-07 with GSK-3 beta. A library of analogs was designed and synthesized, and the new inhibitor MH-124 exhibited clear selectivity for GSK-3 alpha.

BIOORGANIC CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Stable kinetochore-microtubule attachment requires loop-dependent Ndc80-Ndc80 binding

Soumitra Polley, Helen Mueschenborn, Melina Terbeck, Anna De Antoni, Ingrid R. Vetter, Marileen Dogterom, Andrea Musacchio, Vladimir A. Volkov, Pim J. Huis In 't Veld

Summary: During cell division, the Ndc80 complex plays a crucial role in linking chromosomes to spindle microtubules. This study demonstrates that the Ndc80 loop promotes direct interactions between adjacent Ndc80 complexes, which are necessary for stable end-on kinetochore-microtubule attachment and spindle assembly checkpoint satisfaction. Mutations in the loop impair these interactions and lead to cell arrest in mitosis.

EMBO JOURNAL (2023)

Article Chemistry, Medicinal

Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor

Rohit Arora, Joannes T. M. Linders, Samia Aci-Seche, Thomas Verheyen, Erika Van Heerde, Dirk Brehmer, Apirat Chaikuad, Stefan Knapp, Pascal Bonnet

Summary: The mutation V600E in B-Raf leads to mitogen activated protein kinase (MAPK) pathway activation, uncontrolled cell proliferation, and tumorigenesis. ATP competitive type I B-Raf inhibitors efficiently block the MAPK pathways in B-Raf mutant cells but induce conformational changes in the wild type B-Raf (wtB-Raf) kinase domain causing paradoxical hyperactivation. Type II inhibitors prevent heterodimerization by binding the kinase in the DFG-out conformation.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily

Marcel Rak, Roberta Tesch, Lena M. Berger, Ekaterina Shevchenko, Monika Raab, Amelie Tjaden, Rezart Zhubi, Dimitrios-Ilias Balourdas, Andreas C. Joerger, Antti Poso, Andreas Kra, Lewis Elson, Aleksandar Luc, Thales Kronenberger, Thomas Hanke, Klaus Strebhardt, Mourad Sanhaji, Stefan Knapp

Summary: Salt-inducible kinases 1-3 (SIK1-3) are important regulators of cellular homeostasis. This study presents a structure-based approach to improve the selectivity of inhibitors targeting SIK kinases, resulting in the development of a valuable tool compound, MR22, which showed excellent selectivity and phenotypic effects in ovarian cancer cells.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore

Han Wee Ong, Anna Truong, Frank Kwarcinski, Chandi de Silva, Krisha Avalani, Tammy M. Havener, Michael Chirgwin, Kareem A. Galal, Caleb Willis, Andreas Kramer, Shubin Liu, Stefan Knapp, Emily R. Derbyshire, Reena Zutshi, David H. Drewry

Summary: Malaria is a global health problem with high morbidity and mortality rates. The emergence of drug resistance against current treatments emphasizes the need for alternative antimalarials. In this study, we discovered Ki8751 as an inhibitor of essential kinase PfPK6 and identified two compounds (67 and 79) with potent antiplasmodial activity against both blood and liver stages of malaria.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition

Maria Mushtaq Ali, Sehrish Naz, Sajda Ashraf, Stefan Knapp, Zaheer Ul-Haq

Summary: BRD9 inhibitors have potential therapeutic value in cancer treatment by selectively targeting BRD9 and BRD7 proteins, regulating chromatin structure and gene expression, and inhibiting tumor growth and progression.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Biochemistry & Molecular Biology

Toward effective Atg8-based ATTECs: Approaches and perspectives

Martin P. Schwalm, Stefan Knapp, Vladimir V. Rogov

Summary: Induction of LC3/GABARAP protein interactions with target proteins by small molecules has the potential for targeted protein degradation, but no potent ligands have been developed despite intensive screening campaigns in the past 5 years, limiting its therapeutic applications.

JOURNAL OF CELLULAR BIOCHEMISTRY (2023)

Article Chemistry, Medicinal

Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ

Jun Yong Choi, Yoshihiko Noguchi, James M. Alburger, Simon Bayle, Eugene Chung, Wayne Grant, Apirat Chaikuad, Stefan Knapp, Derek R. Duckett, William R. Roush

Summary: Inhibiting a single kinase isoform is difficult due to the similarity of ATP-binding sites. Through studying crystal structures, a highly selective inhibitor for CK1 & epsilon; (SR-4133) was developed. The mismatch between SR-4133 and CK1 & delta; destabilizes their interaction, while the hydrophobic surface of CK1 & epsilon; enhances the binding of SR-4133, leading to selective inhibition. These potent CK1 & epsilon;-selective inhibitors exhibit nanomolar growth inhibition in bladder cancer cells and inhibit the phosphorylation of 4E-BP1, a downstream effector of CK1 & epsilon;.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B

Emmanuel Deau, Mattias F. F. Lindberg, Freideiric Miege, Didier Roche, Nicolas George, Pascal George, Andreas Kra''mer, Stefan Knapp, Laurent Meijer

Summary: Dual-specificity,tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) have been identified as important targets for various pathologies. In this study, a family of DYRK/CLK inhibitors called Leucettinibs, derived from Leucettines and Leucettamine B, were synthesized and characterized. These inhibitors showed subnanomolar IC50 on DYRK1A and demonstrated potential for therapeutic drug development. Kinase-inactive isomers, iso-Leucettinibs, were also synthesized as suitable negative control compounds. Leucettinibs were found to inhibit DYRK1A substrate phosphorylation in cells.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation

Silvia Arifi, Julian A. Marschner, Julius Pollinger, Laura Isigkeit, Pascal Heitel, Astrid Kaiser, Lennart Obeser, Georg Hoefner, Ewgenij Proschak, Stefan Knapp, Apirat Chaikuad, Jan Heering, Daniel Merk

Summary: The lipid-sensing transcription factor PPAR γ can bind to antidiabetic TZD drugs, oxidized vitamin E metabolites, and vitamin E mimetic garcinoic acid. While the effects of the second binding on PPAR γ activity are unclear, a selective ligand of the second site has been developed, revealing potential noncanonical regulation of PPAR γ activities. This alternative binding diminishes FOXO signaling and may have therapeutic applications.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Cell Biology

5-Iodotubercidin sensitizes cells to RIPK1-dependent necroptosis by interfering with NF & kappa;B signaling

Chanchal Chauhan, Andreas Kraemer, Stefan Knapp, Mark Windheim, Alexey Kotlyarov, Manoj B. Menon, Matthias Gaestel

Summary: This study investigates the role of MAPK-activated protein kinase 2 (MK2) in cell death and identifies 5-Iodotubercidin (5-ITu) as a potent compound that sensitizes MK2-deficient cells to TNF-induced death. It is found that 5-ITu induces RIPK1-dependent necroptosis by suppressing IKK signaling in the absence of MK2 activity.

CELL DEATH DISCOVERY (2023)

Article Biochemistry & Molecular Biology

Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization

Martin P. Schwalm, Andreas Kraemer, Anja Doelle, Janik Weckesser, Xufen Yu, Jian Jin, Krishna Saxena, Stefan Knapp

Summary: Cell-based assays using NanoLuciferase and HaloTag were developed to measure the kinetics and stability of PROTAC-induced degradation and ternary complex formation. Characterization of PROTACs targeting WDR5 revealed the importance of ternary complex formation and stability in the early degradation cascade. Comparison of ternary complex crystal structures highlighted the significance of an efficient E3-target interface for ternary complex stability. This study provides a strategy for the rational optimization of PROTACs using a series of live cell assays monitoring key steps of the early PROTAC-induced degradation pathway.

CELL CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

RZZ-Spindly and CENP-E form an integrated platform to recruit dynein to the kinetochore corona

Verena Cmentowski, Giuseppe Ciossani, Ennio d'Amico, Sabine Wohlgemuth, Mikito Owa, Brian Dynlacht, Andrea Musacchio

Summary: The RZZS complex and CENP-E are closely connected and reciprocally required for their own kinetochore recruitment and dynein localization to the corona.

EMBO JOURNAL (2023)

No Data Available